Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2023-06-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
NCT04022577
Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia
NCT05835583
Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia
NCT02001103
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
NCT00057135
Medication Adherence in Older Adults With Serious Mental Illness
NCT00224380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
The control group only received usual care, the PANSS and MMSE were used to assess psychiatric symptoms and cognitive functions before (week 0) and after 8 weeks.
No interventions assigned to this group
experimental group
The experimental group use the MedAdhere app for eight weeks, the PANSS and MMSE were used to assess psychiatric symptoms and cognitive functions before (week 0) and after (week 8) intervention.
the MedAdhere app
The experimental group downloaded and used the MedAdhere app on their personal smartphones during this 8-week study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the MedAdhere app
The experimental group downloaded and used the MedAdhere app on their personal smartphones during this 8-week study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 20 to 65 years
* able to read traditional Chinese
* owning a smartphone
* currently admitted at a psychiatric day-care center
Exclusion Criteria
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaohsiung Medical University
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chen HH, Hsu HT, Lin PC, Chen CY, Hsieh HF, Ko CH. Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial. JMIR Ment Health. 2023 Dec 14;10:e50806. doi: 10.2196/50806.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMURCT20200096
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.